Literature DB >> 7576180

Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding.

R B Nehring1, W Meyerhof, D Richter.   

Abstract

A highly conserved aspartic acid residue present in the third membrane-spanning region of adrenergic and muscarinic receptors is directly involved in ligand binding. The five cloned somatostatin receptor subtypes also contain this residue at the same relative position. To test whether Asp-124 of the rat somatostatin receptor subtype 3 (SSTR3) is responsible for the binding of somatostain-14 (SST-14), this amino acid residue was replaced by an asparagine or a glutamic acid by polymerase chain reaction (PCR)-mediated site-directed mutagenesis. Expression and binding activity of the wild-type and mutant receptor constructs were studied in COS and HEK cells by ligand binding, UV cross-linking, Western blot, and immunocytochemical analysis. The Asn or Glu mutations result in a significant loss of SST-14 binding, although the mutant receptors are correctly transferred to the cell surface, demonstrating that Asp-124 is directly involved in binding of SST-14.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576180     DOI: 10.1089/dna.1995.14.939

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  10 in total

1.  Construction of a sequence motif characteristic of aminergic G protein-coupled receptors.

Authors:  Enoch S Huang
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

2.  Theoretical analysis of somatostatin receptor 5 with antagonists and agonists for the treatment of neuroendocrine tumors.

Authors:  Santhosh Kumar Nagarajan; Sathya Babu; Thirumurthy Madhavan
Journal:  Mol Divers       Date:  2017-02-02       Impact factor: 2.943

Review 3.  Mode matches and their locations in the hydrophobic free energy sequences of peptide ligands and their receptor eigenfunctions.

Authors:  A J Mandell; K A Selz; M F Shlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

Review 4.  Molecular pharmacology of somatostatin receptor subtypes.

Authors:  Y C Patel
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 5.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

6.  Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.

Authors:  F M Dautzenberg; S Wille; R Lohmann; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

7.  Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment.

Authors:  William L Neumann; Karin E Sandoval; Shirin Mobayen; Mahsa Minaeian; Stephen G Kukielski; Khush N Srabony; Rafael Frare; Olivia Slater; Susan A Farr; Michael L Niehoff; Audrey Hospital; Maria Kontoyianni; A Michael Crider; Ken A Witt
Journal:  RSC Med Chem       Date:  2021-05-26

Review 8.  Somatostatin and somatostatin receptor physiology.

Authors:  Philip Barnett
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

9.  In Silico, In Vitro and In Vivo Pharmacodynamic Characterization of Novel Analgesic Drug Candidate Somatostatin SST4 Receptor Agonists.

Authors:  Boglárka Kántás; Éva Szőke; Rita Börzsei; Péter Bánhegyi; Junaid Asghar; Lina Hudhud; Anita Steib; Ágnes Hunyady; Ádám Horváth; Angéla Kecskés; Éva Borbély; Csaba Hetényi; Gábor Pethő; Erika Pintér; Zsuzsanna Helyes
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

10.  Exploration of Somatostatin Binding Mechanism to Somatostatin Receptor Subtype 4.

Authors:  Rita Börzsei; Balázs Zoltán Zsidó; Mónika Bálint; Zsuzsanna Helyes; Erika Pintér; Csaba Hetényi
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.